Self-Sampling could boost cervical cancer screening in older women

NCT ID NCT07244315

Completed Diagnosis Sponsor: University Hospital, Geneva Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether women aged 50 to 65 can collect their own samples for HPV testing to screen for cervical cancer. About 500 women in Cameroon participated. Those who tested positive for HPV then had a Pap smear and other exams to check for precancerous changes. The goal was to see if this approach works well in low-income countries where standard screening is often difficult.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HPV self-sampling test
What this could lead to: If successful, this screening method could improve early detection of cervical cancer in older women who are often missed by standard tests.
What could go wrong: This is a completed feasibility study, not a treatment trial. Results may not apply to other regions or age groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical intraepithelial neoplasia dysplasia of cervix human papilloma virus infection cervical cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER SCREENING CERVICAL INTRAEPITHELIAL NEOPLASIA HPV INFECTIONS

Contacts and locations

Locations

Bafoussam Regional Hospital

Bafoussam, Cameroon

More trials for these conditions

Other studies related to the condition(s) this trial covers.